INCYTE CORP 4

Pablo J. Cagnoni, President and Global Head of R&D of Incyte Corp (INCY), sold 15,888 shares of common stock for about $1.9 million.

On July 31, 2026, Pablo J. Cagnoni, President and Global Head of R&D of Incyte Corporation, sold 15,888 shares of Incyte common stock at an average price of $119.70 per share, for total proceeds of approximately $1.9 million. Following this transaction, he beneficially owned 215,444 shares of common stock, which include 183,200 shares underlying previously reported restricted stock units and earned performance stock units that have not yet vested. The sale appears to be a discretionary open-market disposition while the filer continues to hold a substantial equity stake in the company.

Filing Facts

CIK

879169

Ticker

INCY

Form

4

Source Type

fda

Accession

0001205703-26-000023

Alert Tier

7